Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Devices

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Revenue projections:

Revenue projections for SYK
Revenue projections for SYK

Investors may be wary of Stryker Corporation as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.

Financial Ratios:

currentRatio 1.893000
forwardPE 22.141346
debtToEquity 72.971000
earningsGrowth 0.559000
revenueGrowth 0.114000
grossMargins 0.650420
operatingMargins 0.272350
trailingEps 8.410000
forwardEps 16.729830

Stryker Corporation's current ratio of 1.893 indicates strong liquidity, meaning the company can comfortably meet its short-term debt obligations. This financial position reflects Stryker Corporation's ability to use its cash reserves and current assets to cover liabilities without facing any cash flow issues.
SYK's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
With positive earnings and revenue growth, SYK is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.
Stryker Corporation's positive gross and operating margins reflect strong profitability and operational efficiency. These metrics indicate the company's ability to control costs while maintaining healthy revenue, contributing to its solid financial performance.
Stryker Corporation's forward EPS is higher than its trailing EPS, suggesting the company is expected to see an increase in profitability this year. This points to positive growth, indicating that Stryker Corporation is projected to improve its financial performance compared to the previous year.

Price projections:

Price projections for SYK
Price projections for SYK

The steady upward revision of SYK's price projections indicates growing confidence in the company's performance. Analysts are becoming increasingly optimistic about SYK's future prospects and potential for growth.

Insider Transactions:

Insider Transactions for SYK
Insider Transactions for SYK


12 Stryker Corporation stock sales were completed, with market price of 375.60500081380206.There were no sell transactions during the given period.With more buying than selling around SYK's current price, investors could be expressing optimism. This trend may suggest that the market expects favorable outcomes for the stock, leading to an increased demand at these levels.

Recommendation changes over time:

Recommendations trend for SYK
Recommendations trend for SYK


Analysts have shown a buy bias for SYK, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to SYK, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.